Elon Musk said his biggest concern about Tesla's Optimus humanoid robot program isn't the immense technical or manufacturing challenges but ensuring he retains strong influence over the future "robot army" as the company scales production.

Tesla’s (TSLA) humanoid robot Optimus is likely feeling a little Pessimus today as it faces a double-pronged attack from Chinese rival Unitree Robotics and U.S. tech giant OpenAI.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off!

The next version of Tesla's humanoid robot will "seem like a human in a robot suit," according to CEO Elon Musk. He was referencing the infamous introduction of the Optimus product, which featured an actor in a bodysuit.

The list of use cases for Tesla's Optimus Bot continues to grow with CEO Elon Musk suggesting the robot could help with surgery someday.

The adult-sized humanoid robot doesn’t take any blows, nor does it land any kicks or punches itself, but its movement is smooth and realistic, and demonstrates the bot’s ability to perform dynamic movements with little apparent difficulty. It also manages to stay upright after taking a pretty aggressive shove from its human opponent.

PharmAGRI is set to acquire ten thousand Tesla Optimus robots. These advanced humanoid machines will be integrated into farm operations and drug manufacturing. This move aims to enhance efficiency and meet strict regulatory standards.

Shares of Tesla fell Thursday, a day after the company said its third-quarter profit dropped 37% and that capital spending would ramp up next year.

Tesla is slated to kick off Magnificent Seven earnings when it reports third-quarter results after the closing bell on Wednesday.